Emphasis on Nutritional Assessment of the Aging Population, Expansion of Home Healthcare Sector & Clinical Significance Shed on Nutrition for Cancer Survivors to Drive the Clinical Nutrition Products Market
The
global market for Clinical Nutrition Products is projected to reach US$60.8
billion by 2025, driven by increasing geriatric and infant population,
rising incidence of chronic diseases like cancer and diabetes, aging population
& high risk of nutritional deficiencies, growing number of preterm births,
and the shift towards home care. Technological advancements related to tube
feeding, and increasing case of gut dysfunction are the other growth drivers.
The global clinical nutrition market is heading for
lucrative gains owing to a number of factors, including increasing geriatric
and infant population, rising incidence of chronic and lifestyle-related
diseases, growing number of malnourished patients, increasing number of preterm
births, and the shift towards home care. Malnutrition is one of the most common
concerns among elderly people and patients suffering from chronic diseases. The
constant rise in the number of geriatric people with weak digestive systems
implies that chronic diseases and loss of appetite are common issues
confronting this age group, thus necessitating administration of clinical
nutrition solutions. Rise in malnutrition cases owing to longer hospital stays
is also necessitating the use of clinical nutrition therapies. Additionally, the
trend towards homecare for the sick and elderly is set to gain further momentum
in the coming years, offering a case for at-home use of clinical nutrition
products. The market is also benefiting from sustained investments being made
by manufacturers as well as government agencies to develop innovative products.
Infant nutrition represents the largest and the fastest
growing product category in the global clinical nutrition products market. The
number of prematurely born babies is witnessing a steady increase across the
world. The demand for safe, high quality, and nutritive products for meeting the
nutritional needs of premature infants, low-weight
infants, and those afflicted by certain medical conditions is thus expected
to fuel growth in the infant nutrition market over the coming years. The clinical
nutrition market is also likely to receive notable boost from strong growth
exhibited by the enteral nutrition segment, owing to ongoing technological
advances related to tubing feeds, along with increasing cases of gut
dysfunction.
As stated by the new market research report on Clinical
Nutrition Products, developed regions of the US and Europe continue to
dominate as the largest markets for the clinical nutrition products market. The
United States represents the largest market worldwide. Rising cases of
malnutrition among the elderly and those suffering from chronic illnesses, increase
in preterm births, high level of awareness about the benefits of clinical
nutrition, and the availability of reimbursement coverage
are the factors driving the market. Emerging markets have emerged as the
frontiers of growth in the clinical nutrition products market. Rising life
expectancies, growth in the number of disease-specific therapies, heightened
awareness about benefits of clinical nutrition, changing lifestyles, and
growing prominence of home-based patient care are driving demand for clinical
nutrition products in emerging nations. Asia-Pacific
represents the fastest growing regional market with a CAGR of 9.5% over the
analysis period.
Major players in the market include Abbott Nutrition,
Baxter International Inc., B. Braun Melsungen AG, Groupe Danone, Fresenius Kabi
AG, Nutricia North America, ICU Medical Inc., Mead Johnson & Company LLC,
Meiji Co. Ltd., Nestlé Health Science S.A, Otsuka Pharmaceutical Factory Inc., among
others.
The research report titled “Clinical
Nutrition Products- Market Analysis, Trends, and Forecasts” announced by Global Industry Analysts Inc., provides a comprehensive review of market
trends, issues, drivers, mergers, acquisitions and other strategic industry
activities of global companies. The report provides market estimates and
projections for all major geographic markets, such as the US, Canada, Japan,
Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe),
Asia-Pacific (Australia, China, India and Rest of Asia-Pacific), The Middle
East & Africa, and Latin America ((Brazil, Mexico and Rest of Latin
America). The market is analyzed by the following product segments - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition.
Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA,
All Rights Reserved.
For
enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
For
cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on LinkedIn
Comments
Post a Comment